VF
KYNB

Virtu Financial’s Kyntra Bio KYNB Stock Holding History

Virtu Financial’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-465
Closed -$119K – 1863
2021
Q3 		$119K Buy
+465
New +$165K 0.01% 1085
2021
Q1 		– Sell
-288
Closed -$267K – 1736
2020
Q4 		$267K Sell
288
-205
-42% -$215K 0.03% 691
2020
Q3 		$506K Buy
493
+136
+38% +$146K 0.09% 282
2020
Q2 		$362K Buy
+357
New +$331K 0.04% 484
2019
Q4 		$452K Buy
421
+186
+79% +$190K 0.04% 460
2019
Q3 		$217K Buy
+235
New +$258K 0.02% 925
2019
Q2 		– Sell
-283
Closed -$385K – 1588
2019
Q1 		$385K Buy
+283
New +$384K 0.02% 683
2018
Q2 		– Sell
-311
Closed -$359K – 2124
2018
Q1 		$359K Buy
+311
New +$410K 0.02% 910

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Virtu Financial's KYNB Position: Q4 2021 in Review

Virtu Financial sold out of Kyntra Bio (KYNB) in Q4 2021, closing a stake of 465 shares — an estimated $119K sold.

Virtu Financial first reported a position in KYNB in Q1 2018 and held it in 8 quarters. The position peaked at $506K in Q3 2020. 162 funds tracked by Wall St. Rank hold KYNB as of Q4 2021.

  • Virtu Financial reported no remaining Kyntra Bio position as of Q4 2021 after selling out during the quarter.
  • Virtu Financial sold 465 Kyntra Bio shares in Q4 2021, an estimated $119K.
  • Virtu Financial first reported a position in Kyntra Bio in Q1 2018 and held it in 8 quarters.
  • Virtu Financial's Kyntra Bio position peaked at $506K in Q3 2020.
  • 162 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2021.

Based on Virtu Financial's 13F filing for Q4 2021, filed 17 Feb 2022.